Russell Investments Group
AGL icon

Russell Investments Group’s Agilon Health AGL Stock Holding History

Russell Investments Group’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$706K Sell
6,589
-14,620
-69% -$958K ﹤0.01% 2629
2026
Q1 		$168K Buy
21,209
+11,734
+124% +$190K ﹤0.01% 2899
2025
Q4 		$163K Sell
9,475
-594
-6% -$11.5K ﹤0.01% 2907
2025
Q3 		$259K Sell
10,069
-6,012
-37% -$227K ﹤0.01% 2720
2025
Q2 		$925K Buy
16,081
+11,800
+276% +$946K ﹤0.01% 2098
2025
Q1 		$463K Buy
4,281
+2,835
+196% +$247K ﹤0.01% 2321
2024
Q4 		$68.7K Buy
1,446
+1,425
+6,786% +$86.1K ﹤0.01% 2756
2024
Q3 		$2.02K Sell
21
-47
-69% -$6.07K ﹤0.01% 3374
2024
Q2 		$11.1K Buy
68
+62
+1,033% +$8.83K ﹤0.01% 3050
2024
Q1 		$939 Sell
6
-60
-91% -$9.98K ﹤0.01% 3140
2023
Q4 		$20.7K Sell
66
-61
-48% -$22.1K ﹤0.01% 2739
2023
Q3 		$56.2K Buy
+127
New +$57.4K ﹤0.01% 2735
2023
Q1 		– Sell
-304
Closed -$123K – 3287
2022
Q4 		$123K Sell
304
-858
-74% -$402K ﹤0.01% 2638
2022
Q3 		$680K Sell
1,162
-2,440
-68% -$1.46M ﹤0.01% 2112
2022
Q2 		$1.96M Buy
+3,602
New +$1.82M ﹤0.01% 1596
2022
Q1 		– Sell
-15,124
Closed -$10.2M – 2736
2021
Q4 		$10.2M Buy
15,124
+12,956
+598% +$7.88M 0.02% 886
2021
Q3 		$1.84M Hold
2,168
– – ﹤0.01% 1876
2021
Q2 		$2.11M Buy
+2,168
New +$1.9M ﹤0.01% 1883

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Russell Investments Group's AGL Position: Q2 2026 in Review

Russell Investments Group reduced its Agilon Health (AGL) stake by 69% in Q2 2026, selling an estimated $958K and leaving 6,589 shares worth $706K. The position accounts for ﹤0.01% of the portfolio, ranked #2629.

Russell Investments Group first reported a position in AGL in Q2 2021 and has held it in 18 quarters since. The position peaked at $10.2M in Q4 2021. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Russell Investments Group held 6,589 shares of Agilon Health worth $706K as of Q2 2026.
  • Russell Investments Group sold 14,620 Agilon Health shares in Q2 2026, an estimated $958K.
  • Agilon Health made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2629 holding.
  • Russell Investments Group first reported a position in Agilon Health in Q2 2021 and has held it in 18 quarters since.
  • Russell Investments Group's Agilon Health position peaked at $10.2M in Q4 2021.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.